Remedy Meds charges no membership fee; medication, unlimited provider visits, phone support, and shipping are bundled into a single monthly price shown after intake. Only the microdose plan price ($189/month) is publicly documented.

Remedy Meds shows pricing only after intake, with a microdose plan captured at $189/month and standard-dose figures reported separately. We compare verified costs, inclusions, and transparency against PlexusDx's published rates.

Remedy Meds publishes no product prices until after intake, but verified evidence shows $189/month microdose and $299–$399/month standard-dose figures. We compare those rates against PlexusDx's published ladder.

PlexusDx charges $129/month for microdose GLP-1; Remedy Meds charges $189/month for the same tier. We compare verified pricing, transparency, and care bundles head-to-head.

Embody publishes standard-dose prices upfront at $299–$349/month. Remedy Meds shows microdose pricing ($189/month) only after intake. PlexusDx lists both tiers with committed-term options: $129/month for microdose and $189/month for semaglutide injection, month-to-month.

MEDVi, Remedy Meds and PlexusDx all offer compounded semaglutide and tirzepatide injections through telehealth, but their recurring prices, first-month structures, cancellation windows and refund rules differ. This three-way comparison lines up the published figures, marks what each provider leaves unpublished, and matches each program to a specific priority.